It is hereby informed that the members of the FCCB COmmittee of the COmpany, have at their meeting held today, 19/Aug/2026, have approved allotment of 48,11,730 fully paid-up equity shares ....

PHIRIII XUDIRIHIII IIIDUXIRIEX Head Otfice : 301, Aura Biplex, Premium Retail Premises, 7, S.V, Hoad, Borivali (West), Mumbai - 4000$2, E-mail ; compliance@sudarshanpharma,com Websile: www.sudarshanpharma.com SoardLine: +91-22-42221111143331111 142221116{100line)c$1p:151496MH2008P1C184997 sPil, / cs / sE I 2026-2027 / 57 Date: 19th Augpst2026 The Listing Department BSE Limited BSE Scrip Code: 543828 Phiroze Jeejeebhoy Towers, BSE Trading Symbol: SUDARSHAN Dalal Street, Mumbai - 400 001 ISIN: INE00TV01023 Dear Sir/Madam, Sub: Outcome of FCCB Committee Meeting of the Company held onWednesday, 19th August,2026 Pursuant to I{egulation 30 of the SEBI (Listing Obligations and Disclosure Rcquirements) Rcgulations, 20L5, it is hereby informed that the members of the FCCB Committee of the Company, by resolution passed at their meeting held on Weclnesday,lgth August, 2026, have approved the allotment of 48,\L,730 (Forty Eight i.akhs Eleven Thousand Seven Hundred And Thirty) fully paid-up equity shares of face value t1/- each upon conversion of Foreign Currency Convertible Bonds (FCCBs) rarorth USD 15,00,000. irursuant to the aforesaid allotment, the following will be the capital structure of the ,rrllr(rrr Particulars Pre-allotment Post-allotment Number of shares 24,96,58,870 25,44,70,600 Issued and Paid Up Capital (in Rs.) 24,96,58,870 25,44,70,600 The details of the shares allotted as above are provided in Annexure-I to this intirnartion. l'he meeting of the Board of Directors commenced at 5.15 pm and concluded at 6.00 pm. We request vou to kindlv take the above information on record. Thanks & Regards, For, Pharma Industries Limited l lemal Chairman & Managing Director Regd. Off. r 301, Aura Biplex, Above Kalyan Jewellers, $.V Hoad, Boriv*li (West), Mumbai - 400092. XUDIRIHIII PHIRIII IIIDUXIRIES tID Head Office : 301, Aura Biplex, Premium Retail Premises, 7, S.V. Road, Borivali (West), lv{umbai - 400092. E-mail : compliance@sudarshanpharma.com Website: www.sudarshanpharma.com BoardLine: +91-22-42221'111 143331111 142221116 (100line)r 611t1 :151496MH2008P1C184997 Annexure I Sr. no. Description Particulars 1 Company name and address Sudarshan Pharma Industries Limited of Registered Office Reg. office: 301, Aura Biplex, Plot no. 7, Above Kalyan Jewellers, S. V. Road, Borivali est , Mumbai 4000:92 2 Name of the recognised Stock BSE Limited Exchange on which the Company's shares are listed I)ate of in-principle approval 26ft September 2025 rcceived from IISE 4 Par value of the shares I{e.1/- per share f, Number of shares allotted 48 77,730 u1 shares 6 Share Ccrtificate No., Not Applicable applicable 7 Issue price per share Rs.30.19 er share 8 Premium per share Rs.29.19 per share 9 Total issued shares after this 25,44,7 0,600 equity shares issue (equity) 10 f'otal issued share capital after Rs.25,44,70,6A0 / - this issue (equity) Whether shares are identical Yes, the shares allotted are identical in all in al1 rcspects to existing respects to the existing equity shares of the shares? If not, when will thev Company and shall rank pari-passu with allotment. I bccome identical? them from the date of For, Sudarshan Pharma Industries Limited Hemal Mchta Chairman & Managing Director Regd. Otf. : 301, Aura Biplex, Above Kalyan Jewellers, $,V, Road, Borivali (!Yest), Mumbai - 400092,